NATH BIOGENES (INDIA)
|
|
BOM : 537291     NSE : NATHBIOGEN     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
May 27,2022 |
Price(EOD): ₹ 192.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Agriculture |
MCap: ₹ 365.18 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
NATH BIOGENES (INDIA) | -3.2% | -19.3% | -54.9% |
BOMBAY BURMAH TRADING CORPORATION | -0.7% | -12% | -22.3% |
VENKYS (INDIA) | -2.3% | -10.6% | -16% |
KAVERI SEED COMPANY | -1.8% | -0.2% | -24.3% |
HARRISONS MALAYALAM | 1.9% | -19.1% | -23.6% |
JK AGRI GENETICS | -2.3% | -17.5% | -19.8% |
BOMBAY SUPER HYBRID SEEDS | 1% | -8.5% | 136% |
SHREE GANESH BIOTECH (INDIA) | -5.3% | -34% | -54.6% |
MANGALAM GLOBAL ENTERPRISE | -3.3% | -2.9% | 315.8% |
FUNDAMENTAL ANALYSIS OF NATH BIOGENES (INDIA)
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF NATH BIOGENES (INDIA)
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
6.56
P/E Calculated based on EPS of 29.29
[ Mar2021 - Standalone Results ] 0.6
P/B Calculated based on Book Value of 322.71
[ Mar2021 - Standalone Results ] 1.19
P/S Calculated based on Revenues of 306.528 Cr
[ TTM - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-0% 21% -5% |
SHARE PRICE MOMENTUM OF NATH BIOGENES (INDIA)
NATH BIOGENES (INDIA) vs SENSEX
DEBT OF NATH BIOGENES (INDIA)
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.16 0.13 0.11 0.13 |
- - - - |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF NATH BIOGENES (INDIA)
Pledged Promoter Shares |
8.38 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF NATH BIOGENES (INDIA)
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
45.78% 35.93% 117.09% 128.19% |
-39.89% -5.87% -35.93% -33.87% |
QtrlyTrend |
0 | |
Latest Qtr: Dec2021 | ||
Quarterly Result Analysis → |
NATH BIOGENES (INDIA) related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE ALLCAP | -0.3% | -7.1% | 7.5% |
S&P BSE FMCG | -1% | 0% | 8.4% |
S&P BSE MIDSMALLCAP | -1.5% | -10.1% | 7.1% |
S&P BSE SMALL CAP | -2.8% | -11.4% | 10% |
You may also like the below Video Courses
FAQ about NATH BIOGENES (INDIA)
Is NATH BIOGENES (INDIA) good for long term investment?
As on May 27,2022, the Fundamentals of NATH BIOGENES (INDIA) look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NATH BIOGENES (INDIA) . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is NATH BIOGENES (INDIA) UnderValued or OverValued?
As on May 27,2022, NATH BIOGENES (INDIA) is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of NATH BIOGENES (INDIA) ?
As on May 27,2022, the Intrinsic Value of NATH BIOGENES (INDIA) is Rs. 192.49 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 192.49
Fair Value [Median EV / Sales Model] : Rs. 158.53
Fair Value [Median Price / Sales Model] : Rs. 203.29
Median Fair Value of NATH BIOGENES (INDIA) : Rs. 192.49
Is NATH BIOGENES (INDIA) trading at a Premium or Discount?
As on May 27,2022, NATH BIOGENES (INDIA) is trading at a Discount of -0% based on the estimates of Median Intrinsic Value!
Quarterly Results of BOMBAY BURMAH TRADING CORPORATION LTD Quarterly Results of VENKYS (INDIA) LTD Quarterly Results of KAVERI SEED COMPANY LTD Quarterly Results of HARRISONS MALAYALAM LTD |
BOMBAY BURMAH TRADING CORPORATION LTD vs VENKYS (INDIA) LTD vs KAVERI SEED COMPANY LTD
NATH BIOGENES (INDIA) LTD vs HARRISONS MALAYALAM LTD vs JK AGRI GENETICS LTD
BOMBAY SUPER HYBRID SEEDS LTD vs SHREE GANESH BIOTECH (INDIA) LTD vs MANGALAM GLOBAL ENTERPRISE LTD
HIMALAYA FOOD LNTERNATIONAL LTD vs MANGALAM SEEDS LTD vs
